Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer

NCT03519971 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: Durvalumab
OTHER: Placebo
DRUG: Cisplatin/ Etoposide
DRUG: Carboplatin/ Paclitaxel
DRUG: Pemetrexed/ Cisplatin
DRUG: Pemetrexed/ Carboplatin
RADIATION: Radiation

Sponsor

AstraZeneca